ABBV vs HUM
By Alex · Tickerpine
AbbVie Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | HUM |
|---|---|---|
| Price | $253.35 | $383.84 |
| Market cap | $447.62B | $46.08B |
| P/E ratio | 123.6 | 41.0 |
| ROE | — | 6.28% |
| Profit margin | 5.79% | 0.82% |
| Revenue growth | 12.40% | 23.50% |
| Dividend yield | 2.73% | 0.92% |
| Beta | 0.31 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs HUM in plain English
- ABBV is the bigger company — about 9.7× the market cap of HUM.
- HUM is cheaper on earnings (P/E 41.0 vs 123.6).
- HUM is growing revenue faster (24% vs 12%).
- ABBV has the higher dividend yield (2.73% vs 0.92%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.